Sort by
Refine Your Search
-
postdoctoral researcher - molecular mechanisms T-cell leukemia - Diagnostische Wetenschappen (28449)
Application Deadline 12 Jun 2025 - 21:59 (UTC) Type of Contract Temporary Job Status Full-time Hours Per Week 38 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is
-
than 12 months in the 36 months immediately before their date of recruitment. The MSCA-DN Programme PhD Scholarship offers a monthly competitive salary to cover living allowance (a country correction
-
Programme. Contact the EU-team to get help to assess your eligibility on a personal basis. Funding The grant provides an allowance to cover living, travel and family costs. In addition, the EU contributes
-
the project fits the scope of Baekeland mandates. Every year in January there is an information session at which the VLAIO programme coordinator explains the modalities of the call. The exact date and link for
-
is that the new infrastructure can take the research to a substantially higher level. The application must include a strong research plan for the first years after acquisition of the infrastructure
-
skills (both oral and written). You have a keen interest in tumor modeling, (single-cell) omic bioinformatics, functional assays. You are highly motivated and can plan and conduct research accurately. You
-
Master programmes International Training Program (ITP) VLIR-UOS finances International Training Programmes (ITP). These are short-term training programmes, lasting one to four months
-
keep us informed (hec@Ghent University.be). Courses at and outside of Ghent University Low Countries Studies is a post academic program for exchange students and other foreign students and researchers
-
your stay. Please keep us informed (hec@Ghent University.be). Courses at and outside of Ghent University Low Countries Studies is a post academic program for exchange students and other foreign students
-
What? The TBM programme provides funding for biomedical research that focuses on new therapies or diagnoses, which are already further on the path from discovery to clinical application and offer a